Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Child Adolesc Psychopharmacol ; 13(4): 523-9, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14977465

RESUMO

OBJECTIVE: To assess the outcome and safety of divalproex treatment in children and adolescents with bipolar disorder. METHODS: We conducted a chart review of children and adolescents who were treated with divalproex and who met Diagnostic and Statistical Manual of Mental Disorders, fourth edition, criteria for bipolar disorder (dose 966 +/- 501 mg/day, level 79.4 +/- 23.1 micro g/mL, duration 1.4 +/- 1.5 years). Responders were defined as those showing moderate to marked response on the Clinical Global Impression-Improvement (CGI-I) scale. RESULTS: Eight of 15 (53%) patients responded to divalproex treatment for mixed episode (n = 6), disruptive behavior (n = 4), pure mania (n = 3), or depression (n = 2). Six of 15 (40%) discontinued divalproex, most due to side effects (n = 5). The most common side effect was weight gain (4/15, 27%). CONCLUSION: In children aged 4-18 years, divalproex treatment was related to improved outcome in the long-term treatment of bipolar disorder. One third of the patients discontinued treatment secondary to side effects, including a case of reversible liver enzyme elevation.


Assuntos
Antimaníacos/uso terapêutico , Transtorno Bipolar/tratamento farmacológico , Ácido Valproico/uso terapêutico , Adolescente , Antimaníacos/efeitos adversos , Transtornos de Deficit da Atenção e do Comportamento Disruptivo/tratamento farmacológico , Transtornos de Deficit da Atenção e do Comportamento Disruptivo/psicologia , Transtorno Bipolar/psicologia , Criança , Pré-Escolar , Transtorno Depressivo/tratamento farmacológico , Transtorno Depressivo/psicologia , Quimioterapia Combinada , Feminino , Humanos , Assistência de Longa Duração , Masculino , Escalas de Graduação Psiquiátrica , Ácido Valproico/efeitos adversos , Aumento de Peso/efeitos dos fármacos
2.
Am J Psychiatry ; 159(7): 1240-2, 2002 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12091209

RESUMO

OBJECTIVE: The authors' goal was to determine if there is an association between brain-to-serum lithium ratios and age. METHOD: Lithium-7 magnetic resonance spectroscopy was used to measure in vivo brain lithium levels in nine children and adolescents (mean age=13.4 years, SD=3.6) and 18 adults (mean age=37.3, SD=9.1) with bipolar disorder. RESULTS: Serum and brain lithium concentrations were positively correlated. Younger subjects had lower brain-to-serum concentration ratios than adults: 0.58 (SD=0.24) versus 0.92 (SD=0.36). The brain-to-serum concentration ratio correlated positively with age. CONCLUSIONS: These observations suggest that children and adolescents may need higher maintenance serum lithium concentrations than adults to ensure that brain lithium concentrations reach therapeutic levels.


Assuntos
Transtorno Bipolar/sangue , Transtorno Bipolar/metabolismo , Química Encefálica , Lítio/análise , Lítio/sangue , Adolescente , Adulto , Fatores Etários , Transtorno Bipolar/tratamento farmacológico , Encéfalo/metabolismo , Criança , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Humanos , Lítio/uso terapêutico , Espectroscopia de Ressonância Magnética , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...